Basic Research in Cardiology

, Volume 78, Issue 4, pp 351–363 | Cite as

Biochemical regulators in cardiac hypertrophy

  • F. Kölbel
  • V. Schreiber
Editorial

Summary

In recent years research has shown that muscle is capable of reacting to mechanical stimuli by altering biochemical processes. Myocardium is probably the source of a biochemical factor, or factors which activate myocardial protein synthesis. In experimentally induced cardiac hypertrophy adaptive alterations have been shown to occur not only in the adrenal medulla but also in the adrenal cortex. Finally, detection of cross reactivity between digitalis glycosides and a number of steroid hormones has succeeded. We assume that such cross reactivity indicates the existence of an endogenic factor of steroid character, which is produced in the adrenal gland and functions as an endogenic cardiotonic agent. During experimental cardiac hypertrophy its synthesis is possibly increased.

We propose the term “endocardin” or “endocardiotonin” for this agent.

Key words

cardiac hypertrophy protein synthesis digitalis glycosides adrenal cortex digoxin-like immunoreactivity 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Aronson, J. K., A. R. Ford, D. G. Grahame-Smith: Techniques for studying the pharmacodynamic effect of cardiac glycosides on patients' own erythrocytes during glycoside therapy. Klin. Wochenschr.59, 1323–1332 (1982).Google Scholar
  2. 2.
    Beznak, M.: Hormonal influences in regulation of cardiac performance. Circulat. Res.14–15, Suppl. II, 141–162 (1964).Google Scholar
  3. 3.
    Bing, O. H. L., S. Matsushita, B. L. Fanburg, H. J. Levine: Mechanical properties of rat cardiac muscle during experimental hypertrophy. Circulat. Res.28, 234–245 (1971).PubMedGoogle Scholar
  4. 4.
    Bodemann, H. H.: Das Problem des zellulären Herzglycosidrezeptors. Klin. Wochenschr.59, 1333–1343 (1982).Google Scholar
  5. 5.
    Bugaisky, L., R. Zak: Cellular growth of cardiac muscle after birth. Texas Rep. Biol. Med.39, 123–138 (1979).Google Scholar
  6. 6.
    Caldarera, C. M., A. Casti, C. Rossoni, O. J. Visioli: Polyamines and noradrenaline following myocardial hypertrophy. J. Mol. Cell. Cardiol.3, 121–126 (1971).PubMedGoogle Scholar
  7. 7.
    Caldarera, C. M., A. Casti, C. Guarnieri, G. Moruzzi: Polyamine and nucleoprotein correlations in hypertrophied and perfused heart. In: Rec. Adv. Stud. Struct. Metabol., vol. 7. pp. 91–97. Ed.: P. Harris, R. J. Bing, A. Fleckenstein, University Park Press (Baltimore 1976).Google Scholar
  8. 8.
    Caldarera, C. M., C. Guarnieri, C. Clô, R. Ferrari, A. Casti: Early biochemical events of myocardial hypertrophy. In: IIIème Réunion de la Section Européenne de l'International Society for Heart Research. pp. 125–138. Ed.: P. Padieu, J.-P. Didier (Dijon, France, 1979).Google Scholar
  9. 9.
    Claycomb, W. C.: Culture of cardiac muscle cells in serum-free media. Exp. Cell Res.131, 231–236 (1980).Google Scholar
  10. 10.
    De Pover, A., G. Castaneda-Hernándes, T. Godfraind: Water versus acetone-HCl extraction of digitalis-like factor from guinea-pig heart. Biochem. Pharmacol.31, 267–271 (1982).PubMedGoogle Scholar
  11. 11.
    Drost, R. H., Th. A. Plomp, A. J. Leunissen, A. H. J. Maas, R. A. A. Maes: A comparative study of the homogenous enzyme immunoassay (EMIT) and two radioimmunoassays (RIAs) for digoxin. Clin. chim. Acta79, 557–567 (1977).PubMedGoogle Scholar
  12. 12.
    Fishman, M. C.: Endogenous digitalis-like activity in mammalian brain. Proc. Nat. Acad. Sci. U.S.76, 4661–4663 (1979).Google Scholar
  13. 13.
    Gibson, K., P. Harris: The effects of polyamines on cardiac protein biosynthesis. In: Rec. Adv. Stud. Card. Struct. Metabol., vol. 7. pp. 71–73. Ed.: P. Harris, R. J. Bing, A. Fleckenstein, University Park Press (Baltimore 1976).Google Scholar
  14. 14.
    Gibson, K., W. Krelhaus, P. Harris: Some properties of rat myocardial ornithine decarboxylase and the in vitro effects of nucleotides. In: Rec. Adv. Stud. Card. Struct. Metabol., vol. 7. pp. 77–83. Ed.: P. Harris, R. J. Bing, A. Fleckenstein, University Park Press (Baltimore 1976).Google Scholar
  15. 15.
    Gruber, K. A., J. M. Whitaker, V. M. Buckalew Jr.: Endogenous digitalis-like substance in plasma of volume-expanded dogs. Nature287, 743–745 (1980).PubMedGoogle Scholar
  16. 16.
    Gruber, K. A., V. M. Buckalew Jr.: Evidence that natriuretic hormone is a cascading peptide hormone system. In: Hormonal regulation of sodium excretion. p. 349. Ed.: B. Lichardus, R. W. Schrier, J. Ponec. Elsevier-North Holland (Amsterdam 1980).Google Scholar
  17. 17.
    Gudbjarnason, S., H. Teleman, Ch. Chiba, P. Wolf, R. J. Bing: Myocardial protein synthesis in cardiac hypertrophy. J. Lab. Clin. Med.63, 245–253 (1964).Google Scholar
  18. 18.
    Hammond, C. L., E. Wieben, C. L. Markert: Molecular signals for initiating protein synthesis in organ hypertrophy. Proc. Nat. Acad. Sci. U.S.76, 2455–2459 (1979).Google Scholar
  19. 19.
    Hatt, P. Y., C. Ledoux, J. P. Bonvalet: Lyse et synthèse des protéines myocardique au cours de l'insuffisance cardiaque expérimentale. Arch. Mal. Cœur58, 1703–1721 (1965).Google Scholar
  20. 20.
    Haupert, C. T., J. M. Sancho: Sodium transport inhibitor from bovine hypothalamus. Proc. Nat. Acad. Sci. U.S.76, 4658–4660 (1979).Google Scholar
  21. 21.
    Heby, O., L. J. Marton, Ch. B. Wilson, H. M. Martinez: Polyamines: a high correlation with cell replication. Febs Letters50, 1–4 (1975).PubMedGoogle Scholar
  22. 22.
    Heller, M., S. Beck, J. Friedman, H. Hallaq, M. Mersel, A. Pinson, H. Schwalb, E. Smith, E. Yehiel: Digitalis and the plasma membrane. In: IIIème Réunion de la Section Européenne de l'International Society for Heart Research, pp. 84–104. Ed.: P. Padieu, J.-P. Didier (Dijon 1979).Google Scholar
  23. 23.
    Hood, W. P., Ch. E. Rackley, E. L. Rolett: Wall stress in the normal and hypertrophical human left ventricle. Amer. J. Cardiol.22, 550–558 (1968).PubMedGoogle Scholar
  24. 23a.
    Hort, W.: Morphologische und physiologische Untersuchungen an Ratten während eines Lauftrainings und nach dem Training. Virchows Arch.320, 197–237 (1951).PubMedGoogle Scholar
  25. 24.
    Ishikawa, S., G. A. Fattal, Popiewicz, J. P. Wyatt: Functional morphometry of myocardial fibres in cor pulmonale. Amer. Rev. Respir. Dis.105, 358–367 (1972).Google Scholar
  26. 25.
    Kim, Ryung-soon, F. S. la Bella: Endogenous ligands and modulators of the digitalis receptor: some candidates. Pharmac. Ther.14, 391–409 (1981).Google Scholar
  27. 26.
    Kizu, A., K. Nakamura, M. Fujiwara, H. Okamori, I. Kimura, M. Yasumi, T. Minega, M. Tanaka, H. Ijichi: The role of hexose monophosphate pathway (HMP) in cardiac hypertrophy. J. Mol. Cell. Cardiol.13, Suppl. 2, 30 (1980).Google Scholar
  28. 27.
    Kölbel, F.: Protein synthesis in cardiac hypertrophy. Rev. Espagnol. Cardiol., Suppl.II: pp. 157–161 (1972).Google Scholar
  29. 28.
    Kölbel, F.: Metabolism of normal and hypertrophic right ventricle. In: Cor pulmonale chronicum. pp. 87–105. Ed.: S. Daum, Europ. Soc. Cardiol (Munich 1977).Google Scholar
  30. 29.
    Kölbel, F., J. Kapitola, O. Schreiberová, V. Kölbelová: Influence of adrenalectomy on the effects of isoproterenol in the rat. Physiol. Bohemosl.19, 281–285 (1970).Google Scholar
  31. 30.
    Kölbel, F., W. F. H. M. Mommaerts, V. Kölbelová, P. Vančura: Cardiac muscle and liver ribosomes of the rat: The influence of laparotomy and laparotomy combined with adrenalectomy. Experientia26, 361–362 (1970).Google Scholar
  32. 31.
    Kölbel, F., J. Kapitola, J. Šonka, O. Schreiberová: Hormonal and humoral modulation of the effect of isoproterenol. pp. 39–47. In: Les Surcharges Cardiaques, Colloque INSERM (Paris 1972).Google Scholar
  33. 32.
    Kölbel, F., O. Schreiberová: Extracts of overloaded rats' hearts: their influence upon proteosynthesis of the myocardial tissue in vitro. p. 42. Adaptability of the cardiac muscle, Abstracts (Praha 1974).Google Scholar
  34. 33.
    Kölbel, F., V. Dorazilová, L. Kümmel: Human heart aneurysm: Biochemical and morphological characteristics. In: Recent Advances in Studies on Cardiac Structure and Metabolism vol. 6. pp. 431–436. Ed.: A. Fleckenstein, G. Rona, Univ. Park Press (Baltimore 1975).Google Scholar
  35. 34.
    Kölbel, F., V. Schreiber, J. Štěpán, T. Přibyl, I. Gregorová: The endogenous digoxin-like substance endocardin (Abstract). J. Mollec. Cell. Cardiol.13, Suppl. 1, 45 (1981).Google Scholar
  36. 35.
    Kölbel, F., V. Schreiber, T. Přibyl: Reflection on what makes the heart grow. In: Advances in Myocardiology, vol. 4. Ed.: N. Dhalla, J. Chazov, Plenum Publ. Co (New York), 1982.Google Scholar
  37. 36.
    Kölbel, F., V. Schreiber, J. Štěpán, T. Přibyl, I. Gregorová: The endogenous digoxin-like substance-endocardin. In: Advances in Studies on Heart Metabolism, pp. 527–530. Ed.: C. M. Caldarera, P. Harris, CLUEB (Bologna 1982).Google Scholar
  38. 37.
    Krelhaus, W., K. Gibson, P. Harris: The effects of hypoxia, hypertrophy, and diet on rat myocardial ornithine decarboxylase activity. In: Rec. Adv. Stud. Card. Struct. Metabol. vol. 7. pp. 85–89. Ed.: P. Harris, R. I. Bing and A. Fleckenstein. University Park Press (Baltimore 1976).Google Scholar
  39. 38.
    Kyrge, P. K.: Myocardial sodium-potassium pump and its adrenocortical regulation as factors limiting cardiac adaptation to severe physical exertion. (Russian text). Kardiologija16, 15–21 (1976).Google Scholar
  40. 39.
    Lloyd, B. L., R. R. Taylor: Influence of myocardial mechanical activity and coronary blood flow on myocardial digoxin uptake. Cardiovasc. Res.4, 487–493 (1976).Google Scholar
  41. 40.
    Löwenstein, J. M., E. M. Corrill: An improved method for measuring plasma and tissue concentrations of digitalis glycosides. J. Lab. Clin. Med.67, 1048–1050 (1966).PubMedGoogle Scholar
  42. 41.
    Meerson, F. Z.: Compensatory hyperfunction of the heart and cardiac insufficiency. Circulat. Res.10, 250–258 (1962).PubMedGoogle Scholar
  43. 42.
    Meerson, F. Z.: Role of synthesis of nucleid acids and protein in adaptation to the external environment. Physiol. Rev.55, 79–123 (1975).PubMedGoogle Scholar
  44. 43.
    Miller, T. B., J. H. Exton, C. H. Park: A bloc in epinephrine-induced glycogenolysis in hearts from adrenalectomized rats. J. Biol. Chem.246, 3672–3678 (1971).PubMedGoogle Scholar
  45. 44.
    Mori, K. J., H. Izumi, A. Seto: Stimulation and support of haemopoietic stem cell proliferation by irradiated stroma cell colonies in bone marrow culturein vitro. J. Radiat. Res.22, 109–115 (1981).PubMedGoogle Scholar
  46. 45.
    Norman, T. D.: The pathogenesis of cardiac hypertrophy. Progr. Cardiovascul. Dis.4, 439–463 (1962).Google Scholar
  47. 46.
    Onji, T., M.-S. Liu: Ouabain in isolated adult dog heart myocytes. Arch. Biochem. Biophys.207, 148–156 (1981).PubMedGoogle Scholar
  48. 47.
    Pegg, A. E.: Effect of alpha-difluoromethylornithine on cardiac polyamine content and hypertrophy. J. Mol. Cell. Cardiol.13, 881–887 (1981).PubMedGoogle Scholar
  49. 48.
    Rabinowitz, M., R. Zak: Biochemical and cellular changes in cardiac hypertrophy. Amer. Rev. Med.23, 245–262 (1972).Google Scholar
  50. 49.
    Rifka, S. M., J. C. Pita Jr., D. L. Loriaux: Mechanism of interaction of digitalis with estradiol binding sites in rat uteri. Endocrinology99, 1091–1096 (1976).PubMedGoogle Scholar
  51. 50.
    Ross, J. S., N. L. R. Bucher, R. A. Malt: Compensatory renal hypertrophy in eviscerated rats. Cancer Res.34, 502–505 (1974).PubMedGoogle Scholar
  52. 51.
    Sanguansermsri, J., P. György, F. Zilliken: Polyamines in human and cows' milk. Amer. J. Clin. Nutr.27, 859–865 (1974).PubMedGoogle Scholar
  53. 52.
    Schrader, W. T., J. M. Seleznev, W. V. Vedeckis, B. W. O'Malley: Steroid receptor subunit structure. In: Gene regulation by steroid hormones. pp. 77–88. Springer-Verlag (New York 1979).Google Scholar
  54. 53.
    Schreiber, S. S., M. Oratz, M. A. Rothschild, F. Reff: Effect of hydrostatic pressure on isolated cardiac nuclei: Stimulation of RNA polymerase II activity. Cardiovasc. Res.12, 265–268 (1978).PubMedGoogle Scholar
  55. 54.
    Schreiber, V.: Neuropeptides and neurosteroids. (Czech text) Čas. lék. čes.119, 656–659 (1980).Google Scholar
  56. 55.
    Schreiber, V., F. Kölbel, J. Štěpán: Apparent(?) immunoreactivity of digoxin in the sera of rats with cardiac overload — on the problem of endogenous cardiotonic (Endocardin). (Czech text) Čas. lék. čes.119, 768–770 (1980).Google Scholar
  57. 56.
    Schreiber, V., J. Štěpán, I. Gregorová, F. Kölbel, T. Přibyl, J. Jahodová, V. Janovská: Digoxin-like immunoreactivity in serum of hyperthyroid rats with hypertrophy of the heart is not caused by aldosterone. (Czech text) Sborn. lék.82, 305–308 (1980).Google Scholar
  58. 57.
    Schreiber, V., J. Štěpán, F. Kölbel, T. Přibyl, J. Jahodová, V. Kubová: Failure of the aldosterone antagonist spironolactone to inhibit myocardial hypertrophy produced by experimental hyperthyroidism and accompanied by “apparent” digoxin immunoreactivity in the blood. Physiol. bohemoslov.29, 577–579 (1980).PubMedGoogle Scholar
  59. 58.
    Schreiber, V., I. Gregorová, T. Přibyl, J. Štěpán: Digitalis-like biological activity and immunoreactivity in chromatographic fractions of rabbit adrenal extract. Endocr. experiment.15, 229–236 (1981).Google Scholar
  60. 59.
    Schreiber, V., F. Kölbel, J. Štěpán, I. Gregorová, T. Přibyl: Digoxin-like immunoreactivity in the serum of rat with cardiac overload. J. Molec. Cell. Cardiol.13, 107–110 (1981).Google Scholar
  61. 60.
    Schreiber, V., F. Kölbel, J. Štěpán, T. Přibyl, J. Jahodová, V. Kubová: Correlations between adrenal weight and heart weight in rats with a cardiac overload. Physiol. bohemoslov.30, 289–294 (1981).PubMedGoogle Scholar
  62. 61.
    Schreiber, V., J. Štěpán, T. Přibyl, L. Stárka: Digitalis glycoside-like biological activity (inhibition of86Rb+ uptake by red blood cells in vitro) of certain steroids and other hormones. Biochem. Pharmac.30, 3001–3002 (1981).Google Scholar
  63. 62.
    Schreiber, V., F. Kölbel, T. Přibyl, J. Jahodová, V. Kubová: Aminoglutethimide, an inhibitor of adrenal steroidogenesis, blocks heart growth after ligation of the abdominal aorta, and in hyperthyroidism. Phys. bohemoslov.31, 497–502 (1982).Google Scholar
  64. 63.
    Seleznev, J. M., S. M. Danilov, V. N. Smirnov: Separation of three glucocorticoid-binding fractions from cytosol of rat heart. J. Steroid. Biochem.10, 215–220 (1979).PubMedGoogle Scholar
  65. 64.
    Seleznev, J. M., S. M. Danilov, N. G. Volkova, G. V. Kolpakova: Glucocorticoids in the hormonal regulation of cardiac metabolism. pp. 243–259. In: Proceedings of the 4th USA-USSR Joint Symposium on Myocardial Metabolism, September 14–16, 1979.Google Scholar
  66. 65.
    Stoffer, S. S., K. M. Hynes, Nai Siang Jiang, R. J. Ryan: Digoxin and abnormal serum hormone levels. J. Amer. Med. Ass.225, 1643–1645 (1973).Google Scholar
  67. 66.
    Tanaka, M., H. Yamada, T. Matsuvra, K. Fukui, T. Kuribayashi, H. Katsume, A. Kizu, H. Ijichi, Y. Ibata: Morphological study of cardiac hypertrophy induced by cold stress in rats. J. Mol. Cell. Cardiol.13, Suppl. 2, 42 (1981).Google Scholar
  68. 67.
    Turto, H., S. Lindy: Digitoxin treatment and experimental cardiac hypertrophy in the rat. Cardiovasc. Res.7, 482–489 (1973).PubMedGoogle Scholar
  69. 68.
    Van Urk, H., D. Malamud, L. Soler-Montesinos, R. A. Malt: Compensatory hyperplasia with increasing loss of renal mass. Laborat. Invest.38, 674–676 (1978).PubMedGoogle Scholar
  70. 69.
    Vandenburgh, H., S. Kaufman: In vitro model for stretch-induced hypertrophy of skeletal muscle. Science203, 265–268 (1979).PubMedGoogle Scholar
  71. 70.
    Van Vroonhoven, T. J., L. Soler-Montesinos, R. A. Malt: Humoral regulation of renal mass. Surgery72, 300–305 (1972).PubMedGoogle Scholar
  72. 71.
    Wachtlová, M., V. Mareš, B. Oštádal: DNA synthesis in the ventricular myocardium of young rats exposed to intermittent high altitude hypoxia (IHA). An autoradiographic study. Virchows Arch. B. Cell. Path.24, 335–342 (1977).Google Scholar
  73. 72.
    Zak, R., D. A. Fischman: Studies on protein synthesis in heart muscle during development and in experimentally produced hypertrophy. In: Cardiac hypertrophy, pp. 247–257. Ed.: N. Alpert, Acad. Press (New York 1971).Google Scholar
  74. 73.
    Zimmer, H. G., E. Gerlach: Early metabolic alterations during the development of experimentally induced cardiac hypertrophy. Drug Res.30, 2001–2007 (1980).Google Scholar

Copyright information

© Dr. Dietrich Steinkopff Verlag 1983

Authors and Affiliations

  • F. Kölbel
    • 1
    • 2
  • V. Schreiber
    • 1
    • 2
  1. 1.Third Medical Department, Faculty of MedicineCharles UniversityPrague 2Czechoslovakia
  2. 2.Laboratory for Endocrinology and Metabolism, Faculty of MedicineCharles UniversityPrague 2Czechoslovakia

Personalised recommendations